Central nervous system stimulants and sport practice.

L Avois, N Robinson, C Saudan, N Baume, P Mangin, M Saugy
Author Information
  1. L Avois: Swiss Laboratory for Doping Analyses, Lausanne University, Switzerland. lidia.avois@chuv.ch

Abstract

BACKGROUND AND OBJECTIVES: Central nervous system (CNS) stimulants may be used to reduce tiredness and increase alertness, competitiveness, and aggression. They are more likely to be used in competition but may be used during training to increase the intensity of the training session. There are several potential dangers involving their misuse in contact sports. This paper reviews the three main CNS stimulants, ephedrine, amfetamine, and cocaine, in relation to misuse in sport.
METHODS: Description of the pharmacology, actions, and side effects of amfetamine, cocaine, and ephedrine.
RESULTS: CNS stimulants have psychotropic effects that may be perceived to be ergogenic. Some are prescription drugs, such as Ephedra alkaloids, and there are issues regarding their appropriate therapeutic use. Recently attention has been given to their widespread use by athletes, despite the lack of evidence regarding any ergogenic or real performance benefit, and their potentially serious side effects. Recreational drugs, some of which are illegal (cocaine, amfetamines), are commonly used by athletes and cause potential ergolytic effects. Overall, these drugs are important for their frequent use and mention in anti-doping laboratories statistics and the media, and their potentially serious adverse effects.
CONCLUSIONS: Doping with CNS stimulants is a real public health problem and all sports authorities should participate in its prevention. Dissemination of information is essential to prevent doping in sport and to provide alternatives. Adequate training and education in this domain should be introduced.

References

  1. Am J Med. 1993 Feb;94(2):205-11 [PMID: 8430716]
  2. Ann Neurol. 1983 Mar;13(3):337-40 [PMID: 6342508]
  3. Ann Pharmacother. 1992 May;26(5):653-9 [PMID: 1591427]
  4. N Engl J Med. 2000 Dec 21;343(25):1833-8 [PMID: 11117974]
  5. Eur J Appl Physiol Occup Physiol. 1998 Apr;77(5):427-33 [PMID: 9562293]
  6. S Afr Med J. 1971 Mar 6;45(10):247-52 [PMID: 5573329]
  7. Baillieres Best Pract Res Clin Endocrinol Metab. 2000 Mar;14(1):79-88 [PMID: 10932812]
  8. J Am Med Assoc. 1959 May 30;170(5):542-57 [PMID: 13653995]
  9. Ciba Found Symp. 1992;166:96-111; discussion 111-24 [PMID: 1638924]
  10. N Engl J Med. 2003 Feb 6;348(6):487-8 [PMID: 12571254]
  11. Curr Sports Med Rep. 2003 Aug;2(4):220-5 [PMID: 12834578]
  12. Neurology. 1993 Jul;43(7):1313-6 [PMID: 8327131]
  13. Med Sci Sports Exerc. 2001 Aug;33(8):1399-403 [PMID: 11474345]
  14. Phys Sportsmed. 1997 Jan;25(1):32-46 [PMID: 20086864]
  15. J Pharmacol Toxicol Methods. 1993 Apr;29(2):61-8 [PMID: 8318715]
  16. Phys Sportsmed. 1986 Nov;14(11):77-82 [PMID: 27456638]
  17. Fed Proc. 1981 Oct;40(12):2689-92 [PMID: 7286248]
  18. Am J Health Syst Pharm. 1997 Jul 15;54(14):1578 [PMID: 9248599]
  19. Med Sci Sports Exerc. 2002 Feb;34(2):344-9 [PMID: 11828246]
  20. Annu Rev Pharmacol Toxicol. 1993;33:639-77 [PMID: 8494354]
  21. Ciba Found Symp. 1992;166:81-9; discussion 89-95 [PMID: 1638923]
  22. Med Sci Sports. 1977 Summer;9(2):95-9 [PMID: 895434]
  23. Baillieres Best Pract Res Clin Endocrinol Metab. 2000 Mar;14(1):1-23 [PMID: 10932807]

MeSH Term

Amphetamine
Central Nervous System Stimulants
Cocaine
Dopamine Uptake Inhibitors
Doping in Sports
Ephedrine
Humans
Sports

Chemicals

Central Nervous System Stimulants
Dopamine Uptake Inhibitors
Amphetamine
Ephedrine
Cocaine

Word Cloud

Created with Highcharts 10.0.0stimulantseffectsCNSusedmaytrainingcocainesportdrugsuseCentralnervoussystemincreasepotentialmisusesportsephedrineamfetaminesideergogenicregardingathletesrealpotentiallyseriousBACKGROUNDANDOBJECTIVES:reducetirednessalertnesscompetitivenessaggressionlikelycompetitionintensitysessionseveraldangersinvolvingcontactpaperreviewsthreemainrelationMETHODS:DescriptionpharmacologyactionsRESULTS:psychotropicperceivedprescriptionEphedraalkaloidsissuesappropriatetherapeuticRecentlyattentiongivenwidespreaddespitelackevidenceperformancebenefitRecreationalillegalamfetaminescommonlycauseergolyticOverallimportantfrequentmentionanti-dopinglaboratoriesstatisticsmediaadverseCONCLUSIONS:DopingpublichealthproblemauthoritiesparticipatepreventionDisseminationinformationessentialpreventdopingprovidealternativesAdequateeducationdomainintroducedpractice

Similar Articles

Cited By